Tecan Group AG (SWX: TECN)
Health Care · Life Sciences Tools & Services · CH
CHF188.50
-1.36% today · +9.7% 1Y
Tecan Group AG (SWX: TECN) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $2.94B and employs 3,000 people.
Over the last twelve months the share price has gained 9.7%, trading between 110.60 and 202.00.
Tweenvest scores Tecan Group AG across four factors: quality 77/100, value 49/100, growth 9/100, dividend 31/100. Its strongest factor is quality.
TECN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.94B
- Revenue (TTM)
- $1.08B
- P/E
- —
- EPS
- -9.30
- Dividend yield
- 1.57%
- Beta (5Y)
- 1.08
- 52-week high
- CHF202.00
- 52-week low
- CHF110.60
- Avg volume (3M)
- —
- Shares outstanding
- 12.32M
- Employees
- 3,000
- Next earnings
- —
About Tecan Group AG
Tecan Group AG, established in 1980 and headquartered in Männedorf, Switzerland, specializes in providing cutting-edge laboratory instruments and holistic solutions. The company caters to a broad spectrum of clients, including pharmaceutical and biotechnology corporations, university research departments, and forensic and diagnostic laboratories. Its operations are structured into two principal segments: Life Sciences Business and Partnering Business. Tecan's extensive product portfolio features automated liquid handling systems, microplate readers and washers, various consumables, reagents for Next-Generation Sequencing (NGS), immunoassays, microbodies, and specialized software. Key proprietary solutions include Tecan Laberwax for automated workflows and Resolvex, an intelligent sample preparation system applicable across diverse fields such as genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA. Additionally, Tecan develops and manufactures crucial components—like precision pumps, valves, robotic arms, and developer software—for other laboratory instrument producers serving life science research, diagnostics, and various industrial applications. Its advanced platform-based automation solutions include Synergence, Freedom EVO, and Fluent instruments. The company's global footprint spans Switzerland, other European nations, North America, Asia, and other international markets.
- ISIN
- CH0012100191
- Founded
- 1980
- Listed since
- Apr 10, 1995
- Exchange
- SIX Swiss Exchange
- Currency
- CHF
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $631.14 | +0.48% |
| Danaher CorporationNYSE: DHR | $151.82B | $215.46 | -0.24% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF588.40 | -0.91% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $153.45 | -0.85% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $260.90 | +0.57% |
| Waters CorporationNYSE: WAT | $40.72B | $416.55 | +0.51% |
Figures last refreshed Aug 18, 2026.